| David I Wells, DPM | |
|
1541 Florida Ave Ste 103, Modesto, CA 95350-4438 | |
| (209) 577-3388 | |
| (209) 575-5836 |
| Full Name | David I Wells |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 38 Years |
| Location | 1541 Florida Ave Ste 103, Modesto, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720041957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | E3571 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Medical Center | Modesto, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Valley Medical Foundation | 9830094515 | 1840 |
News Archive
Variation in a taste receptor gene influences taste sensitivity of children and adults, accounting for individual differences in taste preferences and food selection, report a team of researchers from the Monell Chemical Senses Center. In addition to genes, age and culture also contribute to taste preferences, at times overriding the influence of genetics.
The Stowers Institute's Proteomics Center has published a novel method of using normalized spectral counts derived from a series of affinity purifications analyzed by mass spectrometry (APMS) to generate a probabilistic measure of the preference of proteins to associate with one another.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.
› Verified 8 days ago
| Provider Name | Bay Area Foot Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508911892 PECOS PAC ID: 0345329686 Enrollment ID: O20080512000353 |
News Archive
Variation in a taste receptor gene influences taste sensitivity of children and adults, accounting for individual differences in taste preferences and food selection, report a team of researchers from the Monell Chemical Senses Center. In addition to genes, age and culture also contribute to taste preferences, at times overriding the influence of genetics.
The Stowers Institute's Proteomics Center has published a novel method of using normalized spectral counts derived from a series of affinity purifications analyzed by mass spectrometry (APMS) to generate a probabilistic measure of the preference of proteins to associate with one another.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.
› Verified 8 days ago
| Provider Name | Sutter Valley Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
Variation in a taste receptor gene influences taste sensitivity of children and adults, accounting for individual differences in taste preferences and food selection, report a team of researchers from the Monell Chemical Senses Center. In addition to genes, age and culture also contribute to taste preferences, at times overriding the influence of genetics.
The Stowers Institute's Proteomics Center has published a novel method of using normalized spectral counts derived from a series of affinity purifications analyzed by mass spectrometry (APMS) to generate a probabilistic measure of the preference of proteins to associate with one another.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.
› Verified 8 days ago
| Provider Name | First Choice Physician Partners |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104183052 PECOS PAC ID: 0941465322 Enrollment ID: O20120710000480 |
News Archive
Variation in a taste receptor gene influences taste sensitivity of children and adults, accounting for individual differences in taste preferences and food selection, report a team of researchers from the Monell Chemical Senses Center. In addition to genes, age and culture also contribute to taste preferences, at times overriding the influence of genetics.
The Stowers Institute's Proteomics Center has published a novel method of using normalized spectral counts derived from a series of affinity purifications analyzed by mass spectrometry (APMS) to generate a probabilistic measure of the preference of proteins to associate with one another.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David I Wells, DPM 1541 Florida Ave Ste 103, Modesto, CA 95350-4438 Ph: (209) 577-3388 | David I Wells, DPM 1541 Florida Ave Ste 103, Modesto, CA 95350-4438 Ph: (209) 577-3388 |
News Archive
Variation in a taste receptor gene influences taste sensitivity of children and adults, accounting for individual differences in taste preferences and food selection, report a team of researchers from the Monell Chemical Senses Center. In addition to genes, age and culture also contribute to taste preferences, at times overriding the influence of genetics.
The Stowers Institute's Proteomics Center has published a novel method of using normalized spectral counts derived from a series of affinity purifications analyzed by mass spectrometry (APMS) to generate a probabilistic measure of the preference of proteins to associate with one another.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells.
› Verified 8 days ago
Ronald D. Jensen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-524-1211 | |
Associated Podiatry Group Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 730 16th St, Modesto, CA 95354 Phone: 209-529-9450 Fax: 209-529-3439 | |
Dr. H Rand Tolboe, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1401 Spanos Ct, Suite 104, Modesto, CA 95355 Phone: 209-525-3150 Fax: 209-525-3153 | |
H. Rand Tolboe, D.p.m. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1401 Spanos Ct, Suite 104, Modesto, CA 95355 Phone: 209-525-3150 Fax: 209-525-3153 | |
David R. Collman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-557-1000 | |
Tolboe Foot & Ankle, Inc., A Podiatric Medical Corporation Podiatrist Medicare: Medicare Enrolled Practice Location: 1401 Spanos Court, Suite #104, Modesto, CA 95355 Phone: 209-525-3150 Fax: 209-515-3153 | |
Dr. Rajdeep K Sahota, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 2116 E Orangeburg Ave, Suite A, Modesto, CA 95355 Phone: 209-577-1411 |